tiprankstipranks
Trending News
More News >
Kuros Biosciences (CH:KURN)
OTHER OTC:KURN

Compare Kuros Biosciences (KURN) vs. Competitors

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kuros Biosciences
CHF28.16
CHF1.05B
-164.81
13.86%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.37
CHF133.03M
-2.03
-28.91%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF58.00
CHF706.50M
9.70
35.36%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.78
CHF942.57M
-5.65
376.04%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF30.40
CHF608.44M
25.38
248.22%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF13.58
CHF196.51M
-2.87
4.40%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:KURN
Kuros Biosciences
26.70
3.60
15.58%
CH:MOLN
Molecular Partners AG
3.30
-1.55
-32.06%
CH:BSLN
Basilea Pharmaceutica
58.00
16.80
40.78%
CH:IDIA
Idorsia Ltd
3.78
3.05
422.85%
CH:NWRN
Newron Pharmaceuticals SpA
30.40
21.18
229.72%
CH:SANN
Santhera Pharmaceuticals Holding
14.70
2.38
19.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts